⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL486485 | 0.72 | TSHR (0.31) | — | |
| SCHEMBL19348741 | 0.69 | — | — | |
| Fluoride SCHEMBL12079669 | 0.69 | — | — | |
| Phosphine SCHEMBL28531842 | 0.69 | TSHR (0.35) | — | |
| SCHEMBL517524 | 0.69 | — | — | |
| SCHEMBL12604843 | 0.69 | — | — | |
| SCHEMBL4253621 | 0.69 | — | — | |
| SCHEMBL332472 | 0.67 | — | — | |
| SCHEMBL14035030 | 0.67 | CTSA (0.36) | — | |
| SCHEMBL1634012 | 0.67 | TP53 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3890749-B1 | CDK9 INHIBITORS AND POLYMORPHS THEREOF FOR USE AS AGENTS FOR TREATMENT OF CANCER | SUMITOMO PHARMA AMERICA INC (US) | 2025-10-29 | — | — | EP | disclosed |
| US-20250197432-A1 | CDK9 Inhibitors and Polymorphs Thereof For Use As Agents For Treatment of Cancer | SUMITOMO PHARMA ONCOLOGY INC (US) | 2025-06-19 | — | — | US | disclosed |
| US-12077554-B2 | CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer | SUMITOMO PHARMA ONCOLOGY, INC. (US) | 2024-09-03 | — | — | US | disclosed |
| US-20230250116-A1 | CDK9 Inhibitors and Polymorphs Thereof For Use As Agents For Treatment of Cancer | SUMITOMO PHARMA ONCOLOGY, INC. | 2023-08-10 | — | — | US | disclosed |
| WO-2023134465-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR, INTERMEDIATE THEREOF AND USE THEREOF | 上海艾力斯医药科技股份有限公司 | 2023-07-20 | — | — | WO | disclosed |
| US-11530231-B2 | CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer | SUMITOMO PHARMA ONCOLOGY, INC. (US) | 2022-12-20 | — | — | US | disclosed |
| US-20210332071-A1 | CDK9 Inhibitors and Polymorphs Thereof For Use As Agents For Treatment of Cancer | SUMITOMO PHARMA ONCOLOGY, INC. | 2021-10-28 | — | — | US | disclosed |
| EP-3890749-A1 | CDK9 INHIBITORS AND POLYMORPHS THEREOF FOR USE AS AGENTS FOR TREATMENT OF CANCER | Sumitomo Dainippon Pharma Oncology, Inc. (US) | 2021-10-13 | — | — | EP | disclosed |
| US-11034710-B2 | CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer | SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC. (US) | 2021-06-15 | — | — | US | disclosed |
| US-20200255462-A1 | CDK9 INHIBITORS AND POLYMORPHS THEREOF FOR USE AS AGENTS FOR TREATMENT OF CANCER | SUMITOMO PHARMA ONCOLOGY, INC. | 2020-08-13 | — | — | US | disclosed |
| WO-2009023193-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | CYTOKINETICS, INCORPORATED (US) | 2009-02-19 | — | — | WO | disclosed |
| WO-2009023193-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | CYTOKINETICS, INCORPORATED (US) | 2009-02-19 | — | — | WO | disclosed |
| WO-2008076265-A1 | MONOPHOSPHATES AS MUTUAL PRODRUGS OF ANTI-INFLAMMATORY SIGNAL TRANSDUCTION MODULATORS (AISTM'S) AND β-AGONISTS FOR THE TREATMENT OF PULMONARY INFLAMMATION AND BRONCHOCONSTRICTION | GILEAD SCIENCES, INC. (US) | 2008-06-26 | — | — | WO | disclosed |
| WO-2008076269-A2 | MONOPHOSPHATES AS MUTUAL PRODRUGS OF MUSCARINIC RECEPTOR ANTAGONISTS AND β-AGONISTS FOR THE TREATMENT OF COPD AND CHRONIC BRONCHITIS | GILEAD SCIENCES, INC. (US) | 2008-06-26 | — | — | WO | disclosed |
| EP-1893220-A1 | SUBSTITUTED PHENYLPHOSPHATES AS MUTUAL PRODRUGS OF STEROIDS AND BETA -AGONISTS FOR THE TREATMENT OF PULMONARY INFLAMMATION AND BRONCHOCONSTRICTION | Gilead Sciences, Inc. (US) | 2008-03-05 | — | — | EP | disclosed |
| WO-2006138212-A1 | SUBSTITUTED PHENYLPHOSPHATES AS MUTUAL PRODRUGS OF STEROIDS AND β -AGONISTS FOR THE TREATMENT OF PULMONARY INFLAMMATION AND BRONCHOCONSTRICTION | GILEAD SCIENCES, INC. (US) | 2006-12-28 | — | — | WO | disclosed |
| WO-2005063777-A1 | BENZYLPHOSPHATE AND SUBSTITUTED BENZYLPHOSPHATE PRODRUGS FOR THE TREATMENT OF PULMONARY INFLAMMATION | CORUS PHARMA (US) | 2005-07-14 | — | — | WO | disclosed |
| EP-1156054-B1 | DRUGS CONTAINING PHOSPHORIC ACID DERIVATIVES AS THE ACTIVE INGREDIENT | ONO PHARMACEUTICAL CO (JP) | 2004-04-14 | — | — | EP | disclosed |
| US-6495533-B1 | TUMOR NECROSIS FACTOR INHIBITORS; RHEUMATOID ARTHRITIS, ULCERATIVE COLITIS, CROHN'S DISEASE, HEPATITIS, SEPSIS, HEMORRHAGIC SHOCK, MULTIPLE SCLEROSIS, CEREBRAL INFARCTION, DIABETES, INTERSTITIAL PNEUMONIA, PAIN, HIV | ONO PHARMACEUTICAL CO., LTD. (JP) | 2002-12-17 | — | — | US | disclosed |
| EP-1156054-A1 | DRUGS CONTAINING PHOSPHORIC ACID DERIVATIVES AS THE ACTIVE INGREDIENT | ONO PHARMACEUTICAL CO., LTD. (JP) | 2001-11-21 | — | — | EP | disclosed |